Skip to content

Clinical trials

Neoplasms by Site trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20111
20131
20143
20152
20162
20173
20182
20191
20201
20214
20221
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting10
Terminated5
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AstraZeneca3
Daiichi Sankyo2
Hoffmann-La Roche2
Revolution Medicines, Inc.2
Sumitomo Pharma America, Inc.2
Abbott1
Bioniche Life Sciences Inc.1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site30
Neoplasms26
Carcinoma10
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms10
Digestive System Neoplasms9
Lung Diseases9
Respiratory Tract Diseases9
Respiratory Tract Neoplasms9
Adenocarcinoma8

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.